Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
national top stories
3
×
software
3
×
biotech
cancer
clinical trials
deals
detroit blog main
detroit top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
a2 biotherapeutics
accelerator
aduro biotech
agency
airbnb
akili interactive labs
alicia hager
ally bridge group
alpha-1 antitrypsin
alzheimer's disease
amag pharmaceuticals
amazon web services (aws)
What
bio
admits
ago
alliance
analysis
big
biotech
biotechs
bring
bristol
buy
calls
changing
classes
color
combinator
companies
company
crispr
days
develop
diseases
drug
dug
employing
genetic
goldfinch
growing
hours
incubator
ipo
kidney
kudos
later
lead
leaves
life
medicines
million
myers’s
Language
unset
3
×
Current search:
software
×
unset
×
" national top stories "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
